Digestive Endoscopy · 2020 · 11 citations · 13 references
MedicineSurgeryDysphagiaOncologic SurgerySurgical OncologyDysphagia ManagementDysphagia SurgeryEndoscopic SurgeryEsophageal CancerEsophageal SurgeryStent PlacementEndoscopic StentingEsophageal Cancer PalliationRetrospective Case Study
BACKGROUND AND AIM: In presence of malignant dysphagia, in patients unfit for surgery, the placement of a self-expandable metal stent (SEMS) represents a safe and effective palliative treatment. Esophageal stents (ES) present an over-the-wire mechanism where the stent is deployed under X-ray control. Recently a through-the-scope (TTS) ES was launched. The aim of our retrospective study is to assess the technical and clinical success of the new TTS-ES. MATERIALS AND METHODS: Patients with malignant dysphagia caused by esophageal cancer or ab-extrinsic compression, who underwent TTS esophageal stent in six Italian endoscopic referral centers, were retrospectively reviewed. RESULTS: A total of 40 patients were enrolled. TTS stent placement was successful in 39/40 patients (97.5%). 31 patients had an Ogilvie score of 4, nine an Ogilvie 3. After 2 weeks from stent placement 29 reported Ogilvie score of 0, eight a score of 1. None of the patients developed retrosternal pain requiring drugs. No patient experienced perforation, bleeding or migration. A total of seven patients (18%) developed dysphagia as late adverse event (AE). CONCLUSION: Through-the-scope ES presented less AEs, in terms of bleeding and perforation, if compared to the previous published data. An anti-migration system could be helpful, especially when the stent is placed for "ab-extrinseco" malignant dysphagia.
13
Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.
A L Ogilvie, M W Dronfield, R Ferguson et al. · Gut · 1982 · 342 citations · Full text